Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Enzalutamide 160 / Goserelin 10.8, Prostate Cancer Hormone Sensitive, First Line

Protocol-ID: 1360 V2.0 (Mini), ENZA160/GOSE10.8, Prostate Ca (HS), first-line

Indication(s)

  • Prostate Cancer (hormone sensitive); ICD-10 C61
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 11.01.2022